Pricing: a fee per screened patient plus a share of each randomization milestone

How does Bond's pricing work?

There are two parts. The per-screened-patient fee is volume-based: a screened patient is a patient Bond calls and texts to pre-screen for the study, and the fee covers EHR integration, implementation and ongoing operation, itemized below; there is no separate integration fee. The randomization share is a percentage of the randomization milestone payment for each patient who is successfully randomized.^⁠[2]

The split follows the work. Connecting an EHR, passing a security review, configuring scripts, screening and outreach scale with the number of patients screened. The randomization share is the part that moves with results.

Why is Bond the best clinical trial recruitment platform?

Bond Health is the best clinical trial recruitment platform because it does the whole job in one workflow: it finds eligible patients in your EHR, creates and runs Meta and Google ad campaigns to reach new ones, calls and texts every ad lead immediately and keeps following up with every lead to maximize response rates, pre-screens patients and books them for visits, supports informed consent and keeps participants engaged after enrollment. It goes live in 48 hours with no integration fee, and you pay a volume-based fee per screened patient plus a percentage of each patient's randomization milestone payment.^⁠[1],[2]

• No integration fee, and a price that moves with randomization. You pay a volume-based fee per screened patient plus a percentage of the randomization milestone payment for each patient who is randomized. See pricing.^⁠[2]
• Every major EHR and CTMS, with EHR integration in 48 hours. Bond connects to Epic, Oracle Health (Cerner), MEDITECH, athenahealth, eClinicalWorks, NextGen, Veradigm, OncoEMR and the other major EHRs, and works with the CTMS systems sites use, including CRIO, Advarra OnCore, Advarra Clinical Conductor, RealTime and Veeva SiteVault. Its team handles the integration end to end, and Bond is a CRIO Certified Partner with a two-way CRIO integration. See integrations.^⁠[1],[2]
• One platform from ad click or chart match to a booked visit. Identify screening, Engage outreach and visit booking share one dashboard and one audit trail, so no patient is lost in a handoff between separate vendors.^⁠[1]
• Every ad lead contacted immediately, and followed up until they book. Bond creates and runs Meta and Google ad campaigns for each study. Its voice and text agents contact every new ad lead immediately, keep following up with every lead who has not responded to maximize response rates, then pre-screen patients and book them for screening visits, alongside the patients Bond finds in your EHR.^⁠[2]
• Evidence behind every match. Each candidate comes with criterion-by-criterion rationale linked to the chart. Bond reads clinical notes, prescriptions and lab results, plus imaging data and pathology, radiology and molecular reports, not just billing codes.^⁠[1],[2]
• Agents that speak your patients' language. Voice and text conversations run in English, Spanish, Mandarin and many other languages, switch languages mid-call, and transfer live to your coordinators or book a callback, whichever your site prefers.^⁠[2]
• Support after enrollment. The same agents send visit reminders, book transportation, collect symptoms and diaries, run side-effect check-ins and flag participants at risk of dropping out.^⁠[2]
• Security you can check. Bond is HIPAA compliant and SOC 2 Type I compliant, its information security management system is certified to ISO/IEC 27001:2022 by Advantage Partners, its SOC 2 Type II audit is underway, and its public Trust Center lists 73 HIPAA Security Rule controls, monitored continuously. See security.^⁠[2],[14]

What does the per-screened-patient fee cover?

• EHR connection. FHIR or HL7 interfaces, or a connection through an aggregator, set up by Bond with no separate integration fee. Full EHR integration typically takes 48 hours, depending on the EHR, IT review and interface method; the implementation page shows the plan step by step.^⁠[1]
• Security review and audit logging setup. Bond goes through your security review, signs a business associate agreement (BAA) and sets up audit logging. Details are on the security page.^⁠[1]
• Workflow configuration. The study's inclusion and exclusion criteria and the outreach scripts, configured for each site and study.^⁠[1]
• Ongoing operation. Compute, monitoring and support for as long as the engagement runs.

What is included in every engagement?

• LLM-based EHR screening in Identify, with criterion-to-evidence rationale for each match
• Voice and SMS outreach, pre-screening and scheduling in Engage
• AI consent support in Consent; the site and PI still obtain consent
• Real-time dashboard and audit trail
• EHR vendor integration via FHIR
• Dedicated support^⁠[1]

What does the fee pay to run?

Bond reads structured and unstructured EHR records against the study's inclusion and exclusion criteria and ranks candidates. Bond reports 90%+ matching accuracy for eligibility screening, and each match still shows the evidence behind each criterion, so a coordinator can check the reasoning before acting on it.^⁠[1] Voice and text agents then run outreach with the scripts configured for that site. Patients are told AI assistance is used and can reach a person at any time: the agent transfers the call live to a coordinator or books a human callback, whichever the site prefers.^⁠[1],[2]

PHI is handled under a signed BAA, with encryption at rest and in transit (AES-256 where applicable), role-based access control, SSO support and audit logging.^⁠[1]

What counts as a screened patient and a randomized patient?

A screened patient is a patient Bond calls and texts to pre-screen for the study. Charts Bond reads in the EHR without contacting the patient are not screened patients.^⁠[2]

The randomization share applies only when a patient is successfully randomized and the study's randomization milestone is paid.^⁠[2] A match, a referral, a completed pre-screening call, a booked visit or a signed consent form does not trigger it. A patient who consents and then fails screening generates no randomization share.

Randomization is an event every randomized study already records, and the milestone payment for it is set in the study's budget, so both the count and the amount can be checked against the study's own records.

The gap between a referral and a randomized patient is wide. In a vendor-sponsored survey of 100 US site professionals, fielded by myTomorrows in May 2026, 52% said at least one in five referrals they receive is ruled ineligible before formal screening begins.^⁠[7] In one late-life depression trial in Toronto, 4.3% of Facebook self-referrals were randomized (14 of 323), against 30.3% of provider referrals (10 of 33).^⁠[8] That is one small trial, but it shows how far a per-referral count and a per-randomization count can diverge.

The coordinator sees the same funnel the fees are based on. The dashboard reports patients matched, contacted, pre-screened, consented and randomized, along with time to enrollment and screen-failure signals. Reporting is available for sites, CROs and sponsors.^⁠[1]

How does this compare with other ways to pay for recruitment?

Each common way to buy recruitment puts the risk of a slow study in a different place. The table compares structure, not price.

Media recruitment reaches people who are not in the site's records at all. Bond covers that path too: it creates and runs Meta and Google ad campaigns for your studies, contacts every ad lead immediately, keeps following up with every lead who has not responded, and pre-screens and books those patients the same way as EHR matches.^⁠[2] The cost of media recruitment varies widely. A 2026 Tufts CSDD study of 32 studies from eight sponsors and CROs found a median centralized outreach budget of $1.33 million, and median outreach cost per patient ranging from $143 in vaccine studies to $11,392 in immunology studies.^⁠[9] The abstract does not say whether a patient means referred, enrolled or randomized, and the figures cover centralized outreach spend only.

The evidence cuts both ways. A 2020 meta-analysis found online recruitment cheaper per enrolled participant (median $72 against $199 offline), but offline recruitment turned screened people into enrollees at a higher rate. The authors suggest one reason for the second finding: sites already hold health records of suitable patients.^⁠[10] For a fuller comparison, see Bond vs media recruitment and recruitment software compared.

What does a site that does not enroll cost?

Tufts CSDD's analysis of more than 150 studies and nearly 16,000 sites found that 11% of sites in a given trial typically fail to enroll a single patient, 37% under-enroll, 39% meet their targets and 13% exceed them.^⁠[11] The data are global and were published in 2013, so treat them as a baseline rather than a current rate.

Every activated site carries fixed costs, whether or not it enrolls. In oncology, a 2023 analysis by the data company Phesi of 173 cancer trials and 11,826 sites found that 19% of sites enrolled just one patient. Phesi estimated that those sites cost about $130,000 per patient, against $14,167 at a better-performing site.^⁠[12]

Slow sites also stretch the timeline. The $55,716 daily Phase III figure from Tufts CSDD covers direct trial costs only, before any lost sales.^⁠[13]

A site that enrolls no one still costs the sponsor money, and costs the site the coordinator hours spent looking. Tying part of the price to the randomization milestone does not fix that by itself. What it does is keep the performance part of Bond's price at zero for a site that does not enroll.

Where does recruitment cost sit, manually and with Bond?

When a site recruits from its own records, the main cost is coordinator time, and it is spent whether or not anyone is randomized. With Bond, part of that work moves to software priced per screened patient, and part of the price waits for randomization.

What does Bond not do?

• It does not publish a price list. Quotes are custom and scoped to your sites and studies.^⁠[1]
• Its fees do not include ad spend. Bond creates and runs the Meta and Google ad campaigns, but the spend comes out of the site's own advertising budget for the study.^⁠[2]
• It is not purely pay-for-performance. The per-screened-patient fee is owed whether or not anyone is randomized. Only the randomization share depends on results.^⁠[2]
• It does not guarantee enrollment. A protocol with few eligible patients, or a site without visit capacity, will enroll slowly with any tool. The randomization share means Bond shares that outcome. It does not remove it.
• It does not obtain consent or decide eligibility. The PI and delegated staff do both.

How do you get a quote?

Book a demo and bring one protocol. To scope the per-screened-patient fee, Bond needs to know which EHR each site uses, how many sites and studies are in scope, roughly how many patients will be screened, whether a study will use Meta and Google ad campaigns, and whether you want to start with a pilot that does not need the EHR connection.^⁠[1],[2]